AVTR vs PATH
Avantor Inc (AVTR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Avantor Inc (AVTR) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AVTR revenue for 2024-12-31 was $6.78B. Net income was $711.5M. Revenue was down 2.6% from 2023-12-31 to 2024-12-31. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AVTR currently screens at market cap $9.36B and trailing P/E 13.3. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AVTR and PATH stock pages for the full models.
Not investment advice.